Cardiovascular Department, Hebei Chest Hospital, Shijiazhuang, China.
Department of Cardiac Surgery, Hebei Chest Hospital, Shijiazhuang, China.
J Cell Biochem. 2019 Jan;120(1):126-134. doi: 10.1002/jcb.27152. Epub 2018 Sep 14.
Clear cell renal cell carcinoma (ccRCC) is the most popular kidney cancer in adults. Metabolic shift toward aerobic glycolysis is a fundamental factor for ccRCC therapy. MicroRNAs (miRNAs) are thought to be important regulators in ccRCC development and progression. Phosphoinositide-dependent kinase 1 (PDK1) is required for metabolic activation; however, the role of PDK1-induced glycolytic metabolism regulated by miRNAs is unclear in ccRCC. So, the purpose of the current study is to elucidate the underlying mechanism in ccRCC cell metabolism mediated by PDK1. Our results revealed that miR-409-3p inhibited glycolysis by regulating PDK1 expression in ccRCC cells. We also found that miR-409-3p was regulated by hypoxia. Our results indicated that PDK1 facilitated ccRCC cell glycolysis, regulated by miR-409-3p in hypoxia.
透明细胞肾细胞癌 (ccRCC) 是成人中最常见的肾癌。有氧糖酵解的代谢转变是 ccRCC 治疗的一个基本因素。微 RNA (miRNA) 被认为是 ccRCC 发生和发展的重要调节因子。磷酸肌醇依赖性激酶 1 (PDK1) 是代谢激活所必需的;然而,miRNA 调控 PDK1 诱导的糖酵解代谢在 ccRCC 中的作用尚不清楚。因此,本研究旨在阐明 PDK1 介导的 ccRCC 细胞代谢的潜在机制。我们的结果表明,miR-409-3p 通过调节 ccRCC 细胞中的 PDK1 表达来抑制糖酵解。我们还发现,miR-409-3p 受到缺氧的调控。我们的结果表明,PDK1 促进了 ccRCC 细胞的糖酵解,这受 miR-409-3p 在缺氧条件下的调节。